semaglutide and cardiovascular Insights into research: Mechanisms, trials, frontiers Cardiovascular outcomes of semaglutide and

19 The number of previous pregnancies was categorised (0, 1, 2), and polymedication was defined as the use of more than one drug, including any other medication

Outcomes included changes in body weight, waist circumference, and cardiometabolic risk factors like blood pressure, cholesterol, and glucose measures

It is prepared by a state-licensed compounding pharmacy based on an individual prescription and should only be used under the guidance of a licensed medical provider.

Apixaban should be used with caution in severe renal impairment (CrCl 15-29 mL/min) and is not recommended when CrCl is below 15 mL/min

Obesity 2023